News

CVS said it will begin filling prescriptions in Massachusetts and Rhode Island in coming weeks and will expand to additional states where abortion is legal "on a rolling basis." "With major retail ...
Samrat "Sam" Khichi walked onto one of the most daunting legal landscapes one could imagine in January 2023. Fresh off a five-year stint as legal chief of Becton, Dickinson & Co., a medical device ...
It's just over a week since pharmacy benefit managers CVS and Express Scripts sued the state of Arkansas over a new ...
Those operational challenges may have contributed to CVS’ decision to shut down the clinical trials unit, Lis said. The healthcare giant is also working to integrate its recent acquisitions of ...
In such a scenario, CVS would have the added pressure of finding a new leader amid fundamental challenges; much like the scenario at Intel (INTC) currently. My bearish view on CVS Health has ...
CVS Health (NYSE:CVS ... charts plans for the healthcare company as it has been grappling with financial challenges, particularly in its Aetna insurance unit—which had caught the interest ...
CVS Health (NYSE:CVS ... Joyner charted plans for the healthcare company as it is grappling with financial challenges, particularly in its Aetna insurance unit—which caught the interest of ...
lessening CVS' standard of care. Across the aisle, Bondurant Mixson & Elmore partners Naveen Ramachandrappa and Michael Terry, Pete Law and Brian Kaplan of Law & Moran and James Rice and Andrew ...
CVS Health Corp. and CVS Pharmacy reached a tentative settlement in a proposed class-action lawsuit accusing the company of making job applicants take a lie detector test during the interview ...
ST. LOUIS (AP) — Attorneys general in 20 conservative-led states warned CVS and Walgreens on Wednesday that they could face legal consequences if they sell abortion pills by mail in those states.
CVS Health's announcement that it will enter the kidney home dialysis market presents the company with as many challenges as opportunities, says industry analyst Jack Curran. "The dialysis market ...